the initiation of dialysis. [13] [14] [15] Several studies have demonstrated a dose-response relationship between duration of dialysis and adverse post-transplant outcomes, but they focused their analysis on periods of dialysis of <6 years. [16] [17] [18] [19] [20] [21] [22] Notably, 2 of these studies concluded that a long interval of dialysis exposure prior to waitlisting was, compared to the interval of time after waitlisting, a stronger predictor of death after transplant. 21, 22 This difference was attributed to time to waitlisting reflecting not only the risk of dialysis but also access to healthcare and degree of comorbidity. Prior work on the effect of prolonged DT prior to transplantation was derived from single-center studies and reached contradictory conclusions. 23, 24 Given the absence of clear data on the relationship between DT ≥10 years and transplant outcomes and the substantial changes in waitlist priority with KAS, we aimed to answer 3 questions. First, 
| PATIENTS AND ME THODS

| Data source
Analyses were conducted using a Standard Transplant Analysis and
Research (STAR) file provided by the United Network for Organ
Sharing (UNOS)/Organ Procurement and Transplantation Network (OPTN).
| Study populations
The study included 2 cohorts of patients. The first, the waitlist cohort, included patients ≥18 years of age who were placed on the renal transplant waitlist from January 1, 1998-December 31, 2010.
Patients listed as receiving renal replacement therapy but missing the date of dialysis initiation were excluded. Prior renal transplant recipients being relisted or re-transplanted were excluded to avoid misclassification of their degree of dialysis exposure over multiple listings. Multi-organ transplant candidates were excluded because allocation occurs through separate policy. The second, the transplant cohort, included patients ≥18 years of age who a received renal transplant between January 1, 1998 and December 3, 2015. Patients listed as receiving renal replacement therapy but missing the date of dialysis initiation were again excluded. Patients with history of prior renal transplant or receiving multiple organs were excluded for the reasons listed above. Living donor renal transplant recipients were excluded in the transplant cohort because the majority are directed rather than distributed through the allocation system.
| Analytic approach
Outcomes of renal transplant candidates were analyzed within the waitlist cohort. The primary outcomes were (i) transplantation and (ii) death or delisting. The primary exposure was DT at waitlist registration, calculated as the difference between the date of dialysis initiation and the date of placement on the waitlist. Patients were followed from date of registration on the waitlist until transplant, death or delisting, or the end of follow-up (December 3, 2014). The ending date was selected to ensure at least 4 years of follow-up data prior to the initiation of the new KAS (December 4, 2014). A multivariable model for the outcome from waitlisting was fit using
Fine-Gray competing risk regression. 25 Variables included major determinants of access to transplantation including blood group and UNOS-defined geographic region.
Outcomes of kidney transplant recipients were analyzed within the transplant cohort using patients who received renal allografts between January 1, 1998 and December 31, 2012. The primary outcome was graft survival defined as the time from initial transplant to initiation of maintenance renal replacement therapy, retransplant, or death (ie, all-cause allograft failure). The mortality outcome is determined by the SRTR from reports from transplant centers as well as verified external sources, such as the Social Security Administration Death Master File. 26 The secondary outcome was patient survival. Post-transplant graft or patient survival was examined using Kaplan-Meier curves and compared using a log-rank test for equality of survivor functions. A multivariable model for graft failure was fit using Cox regression. The proportional hazards assumption was confirmed with graphical inspection of log-log plots. We adjusted for recipient, donor, and allograft characteristics that were selected based on prior literature and clinical judgment. 
| Missing data
Two covariates had data missing from >1% of patients: PRA (46% in the waitlist cohort and 28% in the transplant cohort) and HCV status (8% in the transplant cohort). For each of these variables, sensitivity
analyses were performed where patients with missing data were first assigned to the lowest category (0% PRA and HCV negative, respectively) and then to the highest category (98%-100% PRA and HCV positive, respectively). For final analysis, multiple imputation was used to generate PRA and HCV status values for individuals with missing values. PRA data were more complete in the year before and the year after KAS implementation with <1% of patients missing data.
| RE SULTS
| Impact of dialysis time on likelihood of renal transplantation: waitlist cohort
Between January 1, 1998 and December 31, 2010, a total of 257 551 patients were added to the renal transplant waitlist and met criteria for inclusion. The majority of patients had either not started dialysis (n = 65 972, 26%) or had been on dialysis for <5 years (n = 175 893, 71%, Table 1 ). Five percent (n = 12 953) had 5-9 years of DT, 1%
(n = 2016) had 10-14 years, 0.2% (n = 462) had 15-19 years, and 0.1% (n = 262) had ≥20 years of dialysis at the time of listing. High PRA (≥86%) patients were relatively more frequent among patients with DT ≥10 years (P < .01, Table S1 ), although they comprised <10%
of registered patients in all cohorts and a substantial number of records were missing PRA data.
As of the conclusion of the period of analysis (March 31, 2016), pre-emptively listed patients were significantly more likely to have received a transplant than patients on dialysis at the time of listing (68% vs 55%, P < .001, Table 1 ). The difference in likelihood of receiving a living donor transplant was particularly pronounced at 29% in pre-emptively listed patients and 12% in those on dialysis (P < .001). Pre-emptively listed patients were also significantly less likely to have died or been delisted without transplant (27% vs 41%, P < .001). As DT at listing increased, patients were progressively less likely to have received a transplant and progressively more likely to have died or been delisted by the end of follow-up. In competing risk regression analysis with death or delisting categorized as a competing risk, increasing durations of dialysis dependence were associated with decreased subhazard ratios (SHR) of receiving a transplant (Table S2 ). This association persisted after adjusting for blood group and UNOS-defined geographic region. PRA was omitted from this model because of the degree of missing data, but, in sensitivity analyses, PRA did not substantially impact the SHR associated with duration of preregistration dialysis dependence.
| Outcomes after transplant by pre-operative dialysis time: transplant cohort
Between January 1, 1998 and December 31, 2012, 109 079 patients received a renal transplant and met criteria for analysis. Demographic characteristics by pretransplant DT are summarized in Table 2 . The cohorts of patients with longer DT were younger, had a lower prevalence of diabetes, and had a higher prevalence of female gender, black ethnicity, high PRA, and hepatitis C infection (P < .001). The greater sensitization in long DT cohorts occurred primarily due to increased frequencies of patients in the 21%-85% PRA range; increases in the 86%-97% and 98%-100% PRA categories also occurred with longer DT but the magnitude of the increase was smaller. These results must be viewed in the context of missing PRA data for 26% of patients. The kidney donor profile index (KDPI) of transplanted organs was higher in patients on dialysis compared to those with no dialysis exposure but the magnitude of the difference was small (P < .001).
The rates of delayed graft function (DGF), graft failure within 30 days, and patient death within 30 days were higher among groups with more years of DT (P < .001, Table 3 ). In multivariate logistic regression analysis, longer DT remained associated with each of these 3 early complications (Tables S3-S5 ). In Kaplan-Meier analysis of long-term transplant outcomes, pre-emptively transplanted patients had superior graft and overall survival compared to all other groups (P < .001, Figure 1 ). Patients with <5 years, 5-9 years, and TA (24) 7348 (32) 941 (39) 155 (35) 50 (28) Glomerulonephritis 602 (6) 4512 (6) 1488 (7) 205 (8) 51 (12) 28 (16) Polycystic kidney disease 1723 (17) 6734 (9) 1353 (6) 153 (6) 29 (7) 14 (8 ≥10 years of DT had overlapping graft and overall survival curves.
Substratifying further, compared to patients with 10-14 years DT, those with 15-19 years and ≥20 years DT had similar graft (P = .86
and .60, respectively, Figure S2A ) and overall survival (P = .40 and .06, respectively, Figure S2B ), although sample size was small.
In multivariable Cox regression analysis, longer DT remained associated with progressively greater hazard of graft failure ( 
| Changes in renal transplantation patterns with new kidney allocation system
The total number of deceased donor kidney transplants was nearly identical in the year prior to and the year following implementation of KAS (9036 and 9031, respectively, Table S6 ). However, patients with DT of 5-9 years, 10-14 years, 15-19 years, and ≥20 years received a substantially higher proportion of the allografts transplanted, and patients with no dialysis exposure or 1-4 years DT received a reduced share of transplants after KAS (P < .001, Table S6 , Figure 2 ).
The magnitude of the increase was greatest in patients with 5-9 years DT (28%-37% of renal transplants, P < .001). The same trend was observed comparing the year after KAS to any year in the decade before KAS implementation (Table S6) . Interestingly, among patients placed on the waitlist in the year prior to and the year following KAS implementation, the number with ≥10 years of dialysis time at the time of registration was nearly identical (1% vs 1%, P = .37).
Highly sensitized patients (PRA 98%-100%) received a significantly greater proportion of renal allografts in the year following KAS implementation compared to the year prior (7% vs 2%, P < .001, Table S7 ). However, the increase in transplants to highly sensitized recipients accounted for only 7% for the total increase in transplants to patients with ≥10 years DT. This study has several limitations. First, the group of prolonged DT patients who are listed for or received renal transplantation are a highly selected group of patients. The multivariable analyses described in the paper only partially adjust for this inherent selection bias and the outcomes described may under-estimate the detrimental effects of prolonged DT in less rigorously selected patients. Important aspects of patient selection cannot be elucidated from SRTR data, as many longterm dialysis patients may never have been referred to transplant evaluation or may have been declined for listing and, in either case, would not appear in SRTR data. This absence limits analysis to candidates who at least were listed for transplant and may provide the most optimistic outcomes that could be expected from this cohort if selection practices significantly change. Second, this study does not identify the cause of the long dialysis times seen in some patients. Poor medical compliance, socioeconomic status, late referral, geography, distance to a transplant center, and lack of awareness of transplantation benefits may all reduce access to transplantation. [37] [38] [39] [40] These factors are not determinable using registry data but should motivate studies using more granular data.
| D ISCUSS I ON
Moreover, these factors may impact post-transplant outcomes and may confound the analysis. Third, our analysis included incomplete records.
We have addressed the missing data to estimate maximum effect of missing data on associations between study outcomes and the primary exposure of interest-dialysis time. Fourth, the long-term outcomes of patients transplanted after the new KAS implementation may be different from pre-KAS patients because of potential differences in patient selection between these periods. The new priority provides substantial incentive to transplant centers to list long DT patients; the prospect of rapidly securing an allograft for these patients may increase programmatic risk tolerance and willingness to list high-risk patients and may unmask differences in outcome that were not evident with prior patient selection patterns. Insufficient follow-up time is available to directly assess these possible impacts on center practice.
In conclusion, prolonged pre-operative dialysis exposure is associ- 
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